Ij. Williamson et al., FREQUENCY OF VOICE PROBLEMS AND COUGH IN PATIENTS USING PRESSURIZED AEROSOL INHALED STEROID PREPARATIONS, The European respiratory journal, 8(4), 1995, pp. 590-592
The aim of the study was to assess the prevalence of throat and voice
symptoms in asthma patients using pressurized aerosol, metered-dose, i
nhaled corticosteroid preparations. A questionnaire was administered t
o hospital out-patients in an asthma clinic and to a control group att
ending a diabetic clinic. Two hundred and fifty five consecutive out-p
atients using pressurized aerosol inhaled corticosteroids and 100 cont
rols were surveyed. One hundred and forty seven (58%) patients taking
inhaled steroids reported voice dysphonia or throat symptoms compared
with 13% of control patients, Women admitted to symptoms more frequent
ly than men, Throat symptoms were more prevalent in patients using hig
her doses of inhaled steroid, Aerosol inhaler-induced cough was report
ed by 87 (34%) patients, Local side-effects were equally prevalent bot
h with beclomethasone dipropionate and budesonide aerosol inhalers. Th
e use of a large volume spacing device with either steroid aerosol did
not appear to protect against these symptoms. Local side-effects are
common in asthmatics taking pressurized aerosol, metered-dose, inhaled
steroids.